CTS Corp Stock Price, News & Analysis

CTS Corporation (NYSE: CTS) declared a $0.04 per share cash dividend payable on Jan 23, 2026 to shareholders of record on Dec 26, 2025. The board also authorized a new $100 million share repurchase program to replace the February 2024 plan.

The repurchase program has no set expiration date and permits buys in the open market or via privately negotiated transactions; timing and amounts will depend on market conditions and other factors.

CTS (NYSE: CTS) announced the appointment of Kimberly Banks MacKay to its Board of Directors, effective November 5, 2025. She will serve on the Nominating, Governance and Sustainability Committee and the Technology and Transactions Committee.

Ms. MacKay has over 30 years of experience in multinational companies and currently serves as SVP, General Counsel and Corporate Secretary of West Pharmaceutical Services. She also holds board and committee roles with the Community Foundation of New Jersey and BAYADA Home Health Care. Company leadership said her healthcare and global business experience supports CTS’s focus on growth, end-market diversification, and its products that sense, connect and move.

CTS Corporation (NYSE: CTS) will participate in the 17th Annual Southwest IDEAS Conference on November 20, 2025 at The Westin Las Colinas, Dallas, TX.

CTS’s presentation is scheduled to begin at 4:00 PM Central Time. A live webcast will be available via a link and from the Investors section of the company website, with a replay accessible on the conference site for one year following the presentation.

CTS (NYSE: CTS)October 28, 2025. Sales were $143 million, up 8% year‑over‑year, with sales to diversified end markets up 22% while transportation sales declined 7%.

Net income was $14 million (9.6% of sales), down from $18 million a year earlier, and diluted EPS was $0.46. Adjusted diluted EPS was $0.60 and adjusted gross margin was 38.9%. Operating cash flow was $29 million. The quarter included an extraordinary $4.2 million EPA-related charge and an unfavorable $0.03 EPS impact from recent US tax legislation.

CTS narrowed 2025 guidance to $535–$545 million in sales and adjusted diluted EPS of $2.20–$2.25, and scheduled a conference call for 10:00 a.m. ET on October 28, 2025.

CTS Corporation (NYSE: CTS) will release Q3 2025 earnings at approximately 8:00 a.m. ET on Tuesday, October 28, 2025. A conference call with management is scheduled the same day at 10:00 a.m. ET to discuss results.

U.S. dial-in numbers are +1-833-470-1428 (toll-free) and +1-646-844-6383 (local); international callers should use the Global Dial In Numbers. The passcode is 815166. A live audio webcast will be available and archived for one year on the CTS investors website at https://investors.ctscorp.com/news-events/events-and-presentations/.

CTS Corporation (NYSE:CTS) has unveiled COBROS, a groundbreaking electric motor control platform that revolutionizes motor sensing technology. The system, developed over seven years of R&D, introduces direct magnetic field measurement capabilities through embedded PCB sensors, replacing traditional indirect measurement methods.

COBROS integrates Hall and TMR sensing elements to enable real-time measurement of both stator and rotor magnetic fields, eliminating the need for separate current and position sensors. This innovation results in simplified design, reduced weight, and enhanced control precision for automotive, industrial, and robotic applications.

CTS Corporation (NYSE: CTS) has announced a quarterly cash dividend payment. The company's Board of Directors declared a dividend of $0.04 per share on outstanding common stock. The dividend will be paid on October 24, 2025, to shareholders of record as of the close of business on September 26, 2025.

CTS Corporation (NYSE: CTS), a manufacturer of custom engineered solutions, reported strong Q2 2025 financial results. Sales reached $135 million, up 4% year-over-year, with diversified end markets growing 13% while transportation segment declined 6%.

The company achieved net income of $19 million (14% of sales), compared to $15 million in Q2 2024. Diluted EPS increased to $0.62 from $0.48, while adjusted diluted EPS rose to $0.57. Adjusted EBITDA margin expanded by 130 basis points to 23.0%, and operating cash flow strengthened to $28 million.

CTS maintained its 2025 guidance, projecting sales of $520-$550 million and adjusted diluted EPS of $2.20-$2.35.

CTS Corporation (NYSE: CTS) has scheduled its second quarter 2025 earnings release and conference call. The company will release Q2 2025 earnings on Thursday, July 24, 2025, at 8:00 a.m. ET, followed by a conference call with management at 10:00 a.m. ET.

Investors can access the call via U.S. toll-free number +1-833-470-1428 or local number +1-404-975-4839 using passcode 932754. A live audio webcast will be available on the company's investor relations website, where it will remain archived for one year.